These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 35482841)
21. Pulmonary hypertension associated with left heart disease. Adir Y; Amir O Semin Respir Crit Care Med; 2013 Oct; 34(5):665-80. PubMed ID: 24037633 [TBL] [Abstract][Full Text] [Related]
22. The Circulating MicroRNA-206 Level Predicts the Severity of Pulmonary Hypertension in Patients with Left Heart Diseases. Jin P; Gu W; Lai Y; Zheng W; Zhou Q; Wu X Cell Physiol Biochem; 2017; 41(6):2150-2160. PubMed ID: 28554172 [TBL] [Abstract][Full Text] [Related]
23. Diastolic Pressure Difference to Classify Pulmonary Hypertension in the Assessment of Heart Transplant Candidates. Wright SP; Moayedi Y; Foroutan F; Agarwal S; Paradero G; Alba AC; Baumwol J; Mak S Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912262 [TBL] [Abstract][Full Text] [Related]
24. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure. Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management. Ltaief Z; Yerly P; Liaudet L Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373119 [TBL] [Abstract][Full Text] [Related]
26. Pathophysiology and Diagnosis of Pulmonary Hypertension Due to Left Heart Disease. Charalampopoulos A; Lewis R; Hickey P; Durrington C; Elliot C; Condliffe R; Sabroe I; Kiely DG Front Med (Lausanne); 2018; 5():174. PubMed ID: 29928642 [TBL] [Abstract][Full Text] [Related]
27. The pathophysiology of pulmonary hypertension in left heart disease. Breitling S; Ravindran K; Goldenberg NM; Kuebler WM Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(9):L924-41. PubMed ID: 26502478 [TBL] [Abstract][Full Text] [Related]
28. Pulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications. Guazzi M; Labate V Curr Heart Fail Rep; 2016 Dec; 13(6):281-294. PubMed ID: 27858232 [TBL] [Abstract][Full Text] [Related]
29. Aldehyde Dehydrogenase 2 (ALDH2) rs671 Polymorphism is a Predictor of Pulmonary Hypertension Due to Left Heart Disease. Tang C; Shi F; Ji Y; Zhu J; Gu X Heart Lung Circ; 2024 Feb; 33(2):230-239. PubMed ID: 38177014 [TBL] [Abstract][Full Text] [Related]
30. Pulmonary Hypertension Due to Left Heart Disease-A Practical Approach to Diagnosis and Management. Lee F; Mielniczuk LM Can J Cardiol; 2021 Apr; 37(4):572-584. PubMed ID: 33217522 [TBL] [Abstract][Full Text] [Related]
31. Lung Capillary Stress Failure and Arteriolar Remodelling in Pulmonary Hypertension Associated with Left Heart Disease (Group 2 PH). Dayeh NR; Ledoux J; Dupuis J Prog Cardiovasc Dis; 2016; 59(1):11-21. PubMed ID: 27195752 [TBL] [Abstract][Full Text] [Related]
32. Left Heart Disease-Related Pulmonary Hypertension. Alamri AK; Ma CL; Ryan JJ Cardiol Clin; 2022 Feb; 40(1):69-76. PubMed ID: 34809918 [TBL] [Abstract][Full Text] [Related]
33. Pulmonary hypertension due to left heart disease. Vachiéry JL; Tedford RJ; Rosenkranz S; Palazzini M; Lang I; Guazzi M; Coghlan G; Chazova I; De Marco T Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545974 [TBL] [Abstract][Full Text] [Related]
34. Pulmonary hypertension associated with left-sided heart disease. Maeder MT; Schoch OD; Kleiner R; Joerg L; Weilenmann D; Swiss Society For Pulmonary Hypertension Swiss Med Wkly; 2017; 147():w14395. PubMed ID: 28102878 [TBL] [Abstract][Full Text] [Related]
35. Recognizing Pulmonary Hypertension and Right Ventricular Dysfunction in Heart Failure. Lala A; Pinney SP Prog Cardiovasc Dis; 2016; 58(4):416-24. PubMed ID: 26780235 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes. Palazzini M; Dardi F; Manes A; Bacchi Reggiani ML; Gotti E; Rinaldi A; Albini A; Monti E; Galiè N Eur J Heart Fail; 2018 Feb; 20(2):248-255. PubMed ID: 28464427 [TBL] [Abstract][Full Text] [Related]
37. Treatment of advanced group 2 PH. Barnett CF; De Marco T Prog Cardiovasc Dis; 2016; 59(1):78-86. PubMed ID: 27417251 [TBL] [Abstract][Full Text] [Related]
38. Under pressure: pulmonary hypertension associated with left heart disease. Farber HW; Gibbs S Eur Respir Rev; 2015 Dec; 24(138):665-73. PubMed ID: 26621980 [TBL] [Abstract][Full Text] [Related]
39. Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension. Ramu B; Houston BA; Tedford RJ Curr Heart Fail Rep; 2018 Apr; 15(2):81-93. PubMed ID: 29417467 [TBL] [Abstract][Full Text] [Related]
40. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort. Miller L; Chartrand S; Koenig M; Goulet JR; Rich É; Chin AS; Chartrand-Lefebvre C; Abrahamowicz M; Senécal JL; Grodzicky T Scand J Rheumatol; 2014; 43(4):314-23. PubMed ID: 25089008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]